18F-FDG-PET/CT for systemic staging of newly diagnosed triple-negative breast cancer Gary A. UlanerRaychel CastilloMithat Gönen Original Article 30 April 2016 Pages: 1937 - 1944
Comparison of RECIST, EORTC criteria and PERCIST for evaluation of early response to chemotherapy in patients with non-small-cell lung cancer Jingjie ShangXueying LingHao Xu Original Article 28 May 2016 Pages: 1945 - 1953
Correlation of metabolic information on FDG-PET with tissue expression of immune markers in patients with non-small cell lung cancer (NSCLC) who are candidates for upfront surgery Egesta LopciLuca ToschiArturo Chiti Original Article 01 June 2016 Pages: 1954 - 1961
Biodistribution and radiation dosimetry of 68Ga-PSMA HBED CC—a PSMA specific probe for PET imaging of prostate cancer Christian H. PfobSibylle ZieglerMatthias Eiber Original Article 20 May 2016 Pages: 1962 - 1970
11C-Choline PET/CT for restaging prostate cancer. Results from 4,426 scans in a single-centre patient series Tiziano GrazianiFrancesco CeciStefano Fanti Original Article 08 June 2016 Pages: 1971 - 1979
Effect of adjuvant lithium on thyroxine (T4) concentration after radioactive iodine therapy Emmanuel NiiBoye HammondMboyo-Di-Tamba Heben Willy Vangu Original Article 28 April 2016 Pages: 1980 - 1987
Prognostic impact of incomplete surgical clearance of radioiodine sensitive local lymph node metastases diagnosed by post-operative 124I-NaI-PET/CT in patients with papillary thyroid cancer Amir SabetIna BinseSandra J. Rosenbaum-Krumme Original Article 27 April 2016 Pages: 1988 - 1994
18F-fluorocholine versus 18F-fluorodeoxyglucose for PET/CT imaging in patients with suspected relapsing or progressive multiple myeloma: a pilot study Thibaut Cassou-MounatSona BalogovaLaurent Garderet Original Article 28 April 2016 Pages: 1995 - 2004
[68Ga]NODAGA-RGD – Metabolic stability, biodistribution, and dosimetry data from patients with hepatocellular carcinoma and liver cirrhosis Roland HaubnerArmin FinkenstedtIrene J. Virgolini Original Article Open access 11 May 2016 Pages: 2005 - 2013
Potential role of 68Ga-DOTATOC PET/CT in screening for pancreatic neuroendocrine tumour in patients with von Hippel-Lindau disease Vikas PrasadNikolaus TilingUrsula Plöckinger Original Article 13 June 2016 Pages: 2014 - 2020
One registration multi-atlas-based pseudo-CT generation for attenuation correction in PET/MRI Hossein ArabiHabib Zaidi Original Article 03 June 2016 Pages: 2021 - 2035
Recommended administered activities for 68Ga-labelled peptides in paediatric nuclear medicine J. Soares MachadoS. BeykanM. Lassmann Short Communication 09 January 2016 Pages: 2036 - 2039
Cerebrospinal fluid lactate levels and brain [18F]FDG PET hypometabolism within the default mode network in Alzheimer’s disease Claudio LiguoriAgostino ChiaravallotiMariangela Pierantozzi Original Article 25 May 2016 Pages: 2040 - 2049
Amyloid- and FDG-PET imaging in amyotrophic lateral sclerosis Jordi A. Matías-GuiuVanesa PytelJosé Luis Carreras Original Article 04 June 2016 Pages: 2050 - 2060
A PET/CT approach to spinal cord metabolism in amyotrophic lateral sclerosis Cecilia MariniAngelina CistaroAdriano Chiò Original Article Open access 15 July 2016 Pages: 2061 - 2071
Current knowledge on the sensitivity of the 68Ga-somatostatin receptor positron emission tomography and the SUVmax reference range for management of pancreatic neuroendocrine tumours Irene VirgoliniMichael GabrielChristian Uprimny Review Article Open access 13 May 2016 Pages: 2072 - 2083
Clinical utility of F-18 FDG PET-CT in the initial evaluation of lung cancer Poul Henning MadsenPaw Christian HoldgaardPoul Flemming Høilund-Carlsen Review Article 11 May 2016 Pages: 2084 - 2097
Interest of multi-modal imaging in bilateral lesions of basal ganglia: A case report of a post-anoxic dystonia Pierre-Maxime DavidNicolas IcardFlorence Le Jeune Image of the Month 13 May 2016 Pages: 2098 - 2099
Ik-Kyung Jang (Ed): Cardiovascular OCT Imaging Valeria GaudieriLuigi Mansi Book Review 12 May 2016 Pages: 2100 - 2100